Core Lithium Ltd (CXO.AX stock) traded at A$0.255 in after-hours trade on 05 Mar 2026 after the company released its results and operational update. The earnings release shows continuing negative EPS of -0.01 and a strong liquidity position with a current ratio of 10.94. Investors will watch near-term production metrics, cash burn and lithium pricing as drivers for any re-rating on the ASX.

CXO.AX stock: Earnings snapshot and headline numbers

Core Lithium reported FY figures that keep EPS at -0.01 and net losses for the last 12 months of A$25.48M. The company holds A$52.22M in cash and only A$3.72M of debt, leaving a net cash position of A$48.50M. One clear takeaway is the funding runway is solid while operating cash flow remained negative at -A$34.31M, linking directly to the stock’s short-term volatility.

CXO.AX stock: Valuation and key ratios

On valuation, Core Lithium posts a negative PE (TTM -23.50) and a price-to-book of 2.20, above the Basic Materials sector average PB of 1.91. Book value per share is A$0.11 and market cap is roughly A$513.95M. The contrast of high current ratio (10.94) and low debt/equity (0.02) points to conservative balance-sheet risk but also highlights limited earnings today.

CXO.AX stock: Technical and trading context

CXO.AX traded between A$0.24 and A$0.255 on the session, with volume at 13,945,097 shares versus a 20-day average near 22,642,614. Short-term indicators show RSI 48.84 and ADX 26.06, suggesting a firm trend but neutral momentum. The 50-day average is A$0.26 and the 200-day average is A$0.16, so recent strength has pushed the price above long-term trends.

CXO.AX stock: Meyka AI grade and analyst framing

Meyka AI rates CXO.AX with a score out of 100: 58.65 (C+, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The company rating from third-party screens shows a conservative view (Rating: C, recommendation: Sell), so our grade reflects stronger balance-sheet metrics but continued operational losses.

CXO.AX stock: Forecasts, price targets and model outlook

Meyka AI’s forecast model projects a quarterly price of A$0.27 and a 3-year target of A$0.3978. Relative to the current price A$0.255, the quarterly projection implies an upside of +5.88% and the 3-year view implies +56.00%. Analysts and market models remain split; reasonable near-term price targets for risk scenarios are A$0.18 (bear), A$0.27 (base) and A$0.35 (bull) for 12 months, reflecting lithium market sensitivity. Forecasts are model-based projections and not guarantees.

CXO.AX stock: Risks, catalysts and what investors should watch

Primary risks include sustained negative operating cash flow, weaker lithium prices and project execution at Finniss. Key catalysts are quarterly production updates, changes in spodumene pricing and off-take contracts. Institutional ownership near 22.60% and insider holdings of 4.06% add context for potential share-supply moves on any funding or contract news.

Final Thoughts

Key takeaways for CXO.AX stock: Core Lithium shows a mixed picture — strong liquidity (A$52.22M cash), low leverage (debt/equity 0.02) and ongoing losses (net loss A$25.48M, EPS -0.01). The stock trades near A$0.255 after hours and sits above the 200-day average, reflecting recent recovery. Meyka AI’s short-term model places a quarterly target of A$0.27 (implied upside +5.88%) while a three-year projection is A$0.3978 (implied upside +56.00%). Our view: near-term moves will be driven by production updates and lithium price direction. Forecasts are model-based projections and not guarantees. For live updates and deeper screening, see the Core Lithium stock page on Meyka’s platform and the detailed company stats at StockAnalysis and Core Lithium profile source company. Meyka AI provides this as an AI-powered market analysis platform insight, not financial advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.